FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to an epigenome repressor of the transcription of gene or genes in human cells, excluding human germ line cells, which is a dCas9 protein linked by a linker to the DNMT3a-L protein, which is linked by a linker to the KRAB repressor domain, which is linked by a linker to the MeCP2 protein. 
EFFECT: invention is effective for scientific experiments in the field of fundamental cell biology, biomedical research in the modeling of hereditary diseases, as well as in treatment of hereditary diseases.
1 cl, 3 dwg
             
         
            
              
                | Title | 
                Year | 
                Author | 
                Number | 
              
							
              
                | TAU MODULATORS AND METHODS AND COMPOSITIONS FOR THEIR DELIVERY | 
                2017 | 
                
									
										- Ledeboer, Annemarie
 - Zeitler, Bryan
 - Zhang, H. Steve
 - Devos, Sarah
 - Hyman, Bradley T.
 - Wegmann, Susanne
 
									 
								 | 
                RU2789459C2 | 
              
							
              
                | METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE | 
                2014 | 
                
									
								 | 
                RU2693891C1 | 
              
							
              
                | METHODS AND COMPOSITIONS FOR HUNTINGTON DISEASE TREATMENT | 
                2013 | 
                
									
										- Miller Dzheffri K.
 - Rebar Edvard Dzh.
 - Chzhan Kh. Stiv
 
									 
								 | 
                RU2639277C2 | 
              
							
              
                | METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE | 
                2015 | 
                
									
										- Froelich Steven
 - Kwak Seung
 - Munoz-Sanjuan Ignacio
 - Zhang H. Steve
 
									 
								 | 
                RU2691102C2 | 
              
							
              
                | SYSTEM FOR ACTIVATING HUMAN APOBEC/AID CYTIDINE DEAMINASES AND/OR HUMAN URACIL-DNA-GLYCOSYLASE UNG AND ITS USE FOR ELIMINATING CCC DNA OF HEPATITIS B VIRUS FROM HUMAN CELLS, PARTICULARLY HEPATOCYTES | 
                2018 | 
                
									
										- Kostyushev Dmitrij Sergeevich
 - Kostyusheva Anastasiya Pavlovna
 - Zarifyan Dmitrij Nikolaevich
 - Brezgin Sergej Alekseevich
 - Chulanov Vladimir Petrovich
 
									 
								 | 
                RU2703532C1 | 
              
							
              
                | CHROMOSOME 9 OPEN READING FRAME 72 GENE EXPRESSION MODULATORS AND APPLICATIONS THEREOF | 
                2020 | 
                
									
										- Nabhan, Joseph F.
 - Pattamatta, Amrutha
 - Samie, Mohammad
 
									 
								 | 
                RU2828216C2 | 
              
							
              
                | SYSTEM FOR INCREASING EFFICIENCY OF MAMMALIAN GENOME EDITING THROUGH HOMOLOGOUS REPAIR | 
                2022 | 
                
									
										- Ivanenko Aleksandr Vyacheslavovich
 - Belousov Vsevolod Vadimovich
 
									 
								 | 
                RU2808045C1 | 
              
							
              
                | SYSTEM FOR ATTRACTING PROTEIN TO DNA BREAK SITE TO INCREASE EFFICIENCY OF MAMMALIAN GENOME EDITING | 
                2022 | 
                
									
										- Ivanenko Aleksandr Vyacheslavovich
 - Belousov Vsevolod Vadimovich
 
									 
								 | 
                RU2808601C1 | 
              
							
              
                | COMPOSITIONS AND METHODS OF GENE EDITING | 
                2019 | 
                
									
										- Chen, Jin
 - Gilbert, Luke
 - Nunez, James
 - Weissman, Jonathan
 
									 
								 | 
                RU2804665C2 | 
              
							
              
                | DELIVERY AND USE OF SYSTEMS OF CRISPR-CAS, VECTORS AND COMPOSITIONS FOR TARGETED ACTION AND THERAPY IN LIVER | 
                2014 | 
                
									
										- Chzhan Fen
 - Tsun Le
 - Zhan Fej
 
									 
								 | 
                RU2716420C2 |